NCT00312988
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Charité Campus Virchow-Klinikum Berlin, Germany
Clinical trial condition
Ovarian Neoplasms
Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.
2,291 public trials
504 recruiting studies
Ovarian Neoplasms trial results
NCT00231075
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Centre Hosptalier Emile Roux Eaubonne, France
- Centre Hospitalier Lyon-sud Pierre-Bénite, France
NCT00028405
- Conditions
- Adnexal Diseases, Anus Diseases, Anus Neoplasms, +54 more
- Locations
-
- University of Arizona, VA Medical Center Tucson, Arizona, United States
- Detroit Medical Center, Wayne State University Detroit, Michigan, United States
- East Carolina State University, Brody School of Medicine Greenville, North Carolina, United States
- University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States
Active, Not Recruiting
Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer
NCT01012817
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
NCT04491942
- Conditions
- Adenoma, Adnexal Diseases, Advanced Bile Duct Carcinoma, +72 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors
NCT04616534
- Conditions
- Adnexal Diseases, Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Neoplasm, +40 more
- Locations
-
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
NCT05554367
- Conditions
- Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, +21 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- UC San Diego Health System - Encinitas Encinitas, California, United States
Active, Not Recruiting
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer
NCT02345265
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
Active, Not Recruiting
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
NCT01366144
- Conditions
- Adnexal Diseases, Breast Carcinoma, Breast Diseases, +70 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
Active, Not Recruiting
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT02595892
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- UC San Diego Medical Center - Hillcrest San Diego, California, United States